|
|
10P Rutgeerts
![]() Summary for 2004 [at-glance overview of P Rutgeerts work for the selected year as suggested by data mining algorithms]This is an Authoratory overview of author P Rutgeerts. According to available data, in 2004 P Rutgeerts published at least 10 articles. This work was completed in collaboration with several authors including Vermeire, S and Van Gossum, A. Many other authors have collaborated with P Rutgeerts as well. There is no information about the funding or the grants awarded to support this work.
P Rutgeerts is a key opinion leader on Crohn Disease, Gastrointestinal Agents. This author's highest rank is 1 when compared to all other authors using the keyword Gastrointestinal Agents. Analysis of the article abstracts and the titles suggests that P Rutgeerts professional interests are focused around "inflammatory bowel disease", "fistulizing crohn disease" and "crohn disease patients". These might also be referred to as "crohn disease", "response infliximab" or "inflammatory bowel". Statistical analysis shows that P Rutgeerts's writing is likely to contains terms "disease", "crohn", "infliximab", "patients", "colitis" and "response".
The affiliations of P Rutgeerts vary, with Department of Gastroenterology, at the University Hospital Gasthuisberg, Leuven, Belgium being the most prominent. Luckily, several email addresses are on file. Images [images we found on the Internet for P Rutgeerts]loading...
Do you know P Rutgeerts who matches the profile above? Click the photo and let us know!
Alternative names (1) [other authors with names similar to P Rutgeerts]Year 2004 Charts [P Rutgeerts frequent coauthors and the most common unique vocabulary terms for the selected year]Historical Performance Charts [graphical overview of P Rutgeerts publication and funding history for the range of years]Emails (3) [email addresses extracted from P Rutgeerts affiliations]hidden to prevent spam, click here to reveal P Rutgeerts Coauthors (41) [all coauthors with the number of joint publications] Other [context-specific ads]Affiliations (7) [condensed summary of the P Rutgeerts affiliations, the leading number and the color conveys importance]- 4Department of Gastroenterology, at the University Hospital Gasthuisberg, Leuven, Belgium.
1Wolfson Unit for Endoscopy, St. Mark's Hospital, Harrow, Middlesex, UK. 1University of Leuven, Belgium. 1Rheumatology Department, CHU Liège, Belgium. 1Department of Gastroenterology, Erasme University Hospital, Brussels, Belgium. 1Department of Gastroenterology, CHU of Liège, Liège, Belgium. 1Laboratory of Experimental Immunology, University Hospital of Leuven, Belgium.
Key Opinion Leader In [P Rutgeerts is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]- 1Gastrointestinal Agents | 5Crohn Disease | 43Colitis, Ulcerative | 105Antibodies, Monoclonal | 587Polymorphism, Genetic
Keywords (32) [keywords assigned to P Rutgeerts articles by PubMed, the leading number and the color conveys importance]- 10Humans | 9Crohn Disease | 8Female | 8Male | 6Gastrointestinal Agents | 6Adult | 5Middle Aged | 4Adolescent | 4Antibodies, Monoclonal | 3Colitis, Ulcerative | 3Polymorphism, Genetic | 3Treatment Outcome | 3Aged | 2Genotype | 2Immunosuppressive Agents | 2Colitis | 2Genetic Predisposition to Disease | 2Prognosis | 1Cytokines | 1C-Reactive Protein | 1Follow-Up Studies | 1Tumor Necrosis Factor-alpha | 1Biological Products | 1Nod2 Signaling Adaptor Protein | 1RNA, Messenger | 1Interferon-gamma | 1Mice, Inbred BALB C | 1Chromosomes, Human, Pair 14 | 1Membrane Glycoproteins | 1Colectomy | 1Epistasis, Genetic | 1Carrier Proteins
P Rutgeerts Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; P Rutgeerts might be a good expert witness on these terms]- 50disease | 35crohn | 27infliximab | 24patients | 18colitis | 15response | 15inflammatory | 14associated | 14treatment | 13bowel | 13polymorphism | 13ibd | 10ulcerative | 9association | 9il-18 | 9population | 8cells | 8cd | 8biological | 7receptor | 7polymorphisms | 7clinical | 7results | 7asp299gly | 7tlr4 | 6factor-alpha | 6conclusion | 6fistulizing | 6perianal | 6necrosis | 6compared | 5methods
- 35crohn disease | 11response infliximab | 11inflammatory bowel | 10ulcerative colitis | 8bowel disease | 7asp299gly polymorphism | 6necrosis factor-alpha | 6confidence interval | 5fistulizing crohn | 5disease patients | 5bone metabolism | 4biological response | 4tumour necrosis | 4infliximab therapy | 4nod2 card15 | 4tlr4 asp299gly | 3polymorphism associated | 3associated crohn | 3bowel disorders | 3bone formation | 3association polymorphism | 3infliximab crohn | 3association response | 3clinical response | 3mg kg | 3perianal fistulizing | 3susceptibility regions | 3disease ulcerative | 3ibd4 locus | 3flemish ibd | 3disease association | 3c-reactive protein
- 8inflammatory bowel disease | 5fistulizing crohn disease | 5crohn disease patients | 4tumour necrosis factor-alpha | 4tlr4 asp299gly polymorphism | 3associated crohn disease | 3polymorphism associated crohn | 3inflammatory bowel disorders | 3therapy crohn disease | 3disease association response | 3disease ulcerative colitis | 3response infliximab crohn | 3infliximab crohn disease | 3biological response infliximab | 3infliximab therapy crohn | 3crohn disease ulcerative | 3association response infliximab | 3clinical response infliximab | 2587g allele frequent | 2gene biological response | 2factor-alpha receptor polymorphisms | 2bowel disease toll-like | 2necrosis factor-alpha receptor | 2nucleotide polymorphisms negatively | 2receptor tlr asp299gly | 2polymorphism igg fc | 2deficient host-bacteria interactions | 2tnfr2 587g allele | 2disease toll-like receptor | 2crohn disease results | 2coding gene biological | 2receptor polymorphisms inflammatory
Reader's Comments (0) [comments posted by readers of P Rutgeerts profile]Funding (0) [selected NIH grants to P Rutgeerts and the award amounts for recent years]- award information is not available
P Rutgeerts Articles (10) [selected PubMed articles for the year 2004 with the links to a full text at PubMed]Balloon dilation of ileocolonic strictures in Crohn's disease. (2004) >> Wolfson Unit for Endoscopy, St. Mark's Hospital, Harrow, Middlesex, UK. 1Brown, G J, 7Saunders, B P, 1Lémann, M, 10Rutgeerts, P.Review article: treatment of perianal fistulizing Crohn's disease. (2004) >> University of Leuven, Belgium. 10Rutgeerts, P.Rapid improvement of bone metabolism after infliximab treatment in Crohn's disease. (2004) >> Rheumatology Department, CHU Liège, Belgium. 7Vermeire, S, 1Fiasse, R, 6Malaise, M, 3Franchimont, D, 3Collette, J, 1Putzeys, V, 6De Vos, M, 3Pelckmans, P, 5Belaiche, J, 5Van Gossum, A, 4Louis, E, 2Franchimont, N, 10Rutgeerts, P.Management of ulcerative colitis and Crohn's disease. (2004) >> Department of Gastroenterology, at the University Hospital Gasthuisberg, Leuven, Belgium. 7Vermeire, S, 4van Assche, G, 1Baert, F, 4D'Haens, G, 10Rutgeerts, P, 2Noman, M.Tumour necrosis factor-alpha receptor 1 and 2 polymorphisms in inflammatory bowel disease and their association with response to infliximab. (2004) >> Department of Gastroenterology, University Hospital Gasthuisberg, Leuven, Belgium. 7Vermeire, S, 2Joossens, S, 1Steen, K V, 3Vlietinck, R, 2Claessens, G, 3Pierik, M, 10Rutgeerts, P.Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. (2004) >> Department of Gastroenterology, Erasme University Hospital, Brussels, Belgium. 7Vermeire, S, 3Van Steen, K, 1Gustot, T, 10Devière, J, 5Van Gossum, A, 1El Housni, H, 2Abramowicz, M, 1Quertinmont, E, 3Pierik, M, 10Rutgeerts, P, 3Franchimont, D.Genome wide scan in a Flemish inflammatory bowel disease population: support for the IBD4 locus, population heterogeneity, and epistasis. (2004) >> Department of Gastroenterology, University Hospital Gasthuisberg, Leuven, Belgium. 7Vermeire, S, 3Van Steen, K, 2Joossens, S, 3Peeters, M, 3Vlietinck, R, 2Claessens, G, 3Pierik, M, 10Rutgeerts, P.The risk of post-operative complications associated with infliximab therapy for Crohn's disease: a controlled cohort study. (2004) >> Department of Gastroenterology, University Hospital Gasthuisberg, Leuven, Belgium. 2D'Hoore, A, 7Vermeire, S, 2Bueno De Mesquita, M, 1Marchal, L, 4van Assche, G, 3Ferrante, M, 1Hiele, M, 4D'Haens, G, 6Penninckx, F, 10Rutgeerts, P, 2Noman, M.Association between polymorphism in IgG Fc receptor IIIa coding gene and biological response to infliximab in Crohn's disease. (2004) >> Department of Gastroenterology, CHU of Liège, Liège, Belgium. 7Vermeire, S, 3Paintaud, G, 6De Vos, M, 1El Ghoul, Z, 5Van Gossum, A, 5Belaiche, J, 1Dall'Ozzo, S, 4Louis, E, 2Watier, H, 3Colombel, J-F, 10Rutgeerts, P.Involvement of interleukin 18 in Crohn's disease: evidence from in vitro analysis of human gut inflammatory cells and from experimental colitis models. (2004) >> Laboratory of Experimental Immunology, University Hospital of Leuven, Belgium. 4van Assche, G, 1Maerten, P, 1Shen, C, 8Ceuppens, J L, 1Bullens, D A M, 1Colpaert, S, 1Vanham, G, 6Penninckx, F, 6Geboes, K, 10Rutgeerts, P, 32Liu, Z.
Science Trivia (2) [Interactive math & science trivia questions]
|
|